Mo1154 NEOADJUVANT THERAPY FOLLOWED BY SURGICAL RESECTION OFFERS BETTER OVERALL SURVIVAL (OS) COMPARED TO UPFRONT SURGICAL RESECTION IN PATHOLOGICAL STAGE II PANCREATIC DUCTAL ADENOCARCINOMA (PDAC): A SURVIVAL ANALYSIS FROM THE NATIONAL CANCER DATABASE (NCDB)